Royal DSM N.V., the global Life Sciences and Materials Sciences Company headquartered in the Netherlands, has announced the following:
Karin Dorrepaal (1961) will join DSM as Senior Vice President in the Corporate Strategy & Acquisitions department, as of September 1, reporting to Hein Schreuder.
At the end of 2011 Karin is to succeed Hein Schreuder (1951), at present Executive Vice President Corporate Strategy & Acquisitions, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board.
Karin, a Dutch national, has had several non executive roles since leaving the Executive Board of Schering AG in Berlin. Within the Schering Board Karin was responsible for the Business Diagnostic Imaging as well as the Global Supply Chain and Procurement. The supply chain activities included responsibility for chemical and pharmaceutical production, operations and related systems. Prior to joining Schering Karin was with Booz Allen & Hamilton (now Booz & Co.) for 14 years, where she was a leader of the Life Science practice. Karin Dorrepaal holds a PhD in Medicine as well as an MBA.
Her very strong external network within the industry will give Karin an excellent starting position to impact the strategic course of DSM.
DSM—the Life Sciences and Materials Sciences Company Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com